Caliper Life Sciences Develops Customized Transfection System for Boehringer Ingelheim
HOPKINTON, Mass., July 30, 2007 -- Caliper Life Sciences, Inc. (NASDAQ: CALP), an
established leader in the field of robotics, is working with the pharmaceutical industry to
develop customized robotic transfection systems for protein expression. Caliper recently
created a unique solution for Boehringer Ingelheim that automates aspects of Baculovirus
expression.
To develop the system for Boehringer Ingelheim, Caliper's Integrated Systems Group (ISG)
worked directly with researchers to understand the company's specific needs for each step of
the Baculovirus expression process. Caliper then utilized its expertise in the field of
laboratory automation and robotics to integrate its Sciclone® liquid handler along with
technology from third-party vendors to create a Staccato® laboratory system that is reliable,
effective and individualized.
Caliper's ISG team, a dedicated team of engineers and scientists with experience in
mechanical and electrical engineering, software development, assay development and project
management expertise, work closely with customers to design and build each system
according to specific needs.
"The capability to develop highly reliable integrated systems illustrates our commitment to
laboratory automation and robotics, and to providing the pharmaceutical industry with
innovative research tools that meet unique needs," said Kevin Keras, Business Unit Manager,
Integrated Systems, Caliper Life Sciences. "We are dedicated to improving the workflow for
drug discovery and development and see tremendous value in partnering with leading system
providers to create solutions that incorporate a broad range of capabilities."
About Caliper Life Sciences
Caliper Life Sciences is a leading provider of cutting-edge technologies enabling researchers
in the life sciences to create life-saving and enhancing medicines and diagnostic tests more
quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap
between in vitro assays and in vivo results and then translate those results into cures for
human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab
automation & liquid handling, optical imaging technologies, and discovery & development
outsourcing solutions. For more information please visit www.caliperLS.com.
Caliper, Sciclone and Staccato are registered trademarks of Caliper Life Sciences, Inc.
